Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Hepatitis C Virus Chronic Infection”

Showing 20 of 0 results

Testing effectiveness (Phase 2)Ended earlyNCT01440595
What this trial is testing

Grazoprevir (MK-5172) With Peg-Interferon and Ribavirin in Participants With Chronic Genotype 2 or 3 Hepatitis C (MK-5172-012)

Who this might be right for
Hepatitis C, Chronic
Merck Sharp & Dohme LLC 5
Large-scale testing (Phase 3)Study completedNCT01276756
What this trial is testing

Efficacy of Nitazoxanide in the Treatment of Chronic Hepatitis C Virus (HCV)

Who this might be right for
Chronic Hepatitis c
Cairo University 100
Early research (Phase 1)Study completedNCT00718172
What this trial is testing

Viral Kinetics and Liver Gene Expression in Response to Ribavirin and Peginterferon Therapy of Chronic Hepatitis C

Who this might be right for
Hepatitis C, Chronic
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) 81
Large-scale testing (Phase 3)Study completedNCT02806505
What this trial is testing

HELPS Study - A Study of Peginterferon Alfa-2a (Pegasys) in Patients With Chronic Hepatitis C (CHC) and End-Stage Renal Disease (ESRD)

Who this might be right for
Hepatitis C, Chronic
Hoffmann-La Roche 81
Testing effectiveness (Phase 2)Study completedNCT00148837
What this trial is testing

Efficacy of Prazosin Versus Placebo Associated With Peg-interferon Alpha 2b and Ribavirin in Chronic Hepatitis C With Genotype 1 or 4 and Severe Fibrosis

Who this might be right for
Hepatitis C, ChronicFibrosis
French National Agency for Research on AIDS and Viral Hepatitis 112
Large-scale testing (Phase 3)Study completedNCT03222583
What this trial is testing

Evaluate the Efficacy and Safety of Glecaprevir/Pibrentasvir (ABT-493/ABT-530) in Treatment-Naive and Treatment-Experienced, Non-Cirrhotic Asian Adults With Chronic Hepatitis C Virus Genotype (GT) 1 to GT6 Infection With or Without Human Immunodeficiency Virus Co-Infection

Who this might be right for
Hepatitis C Virus (HCV)
AbbVie 546
Large-scale testing (Phase 3)Ended earlyNCT01718301
What this trial is testing

HIV Patients With Chronic Hepatitis C Genotype 1 Infection Who Failed Previously to Peginterferon /Ribavirin

Who this might be right for
Hepatitis CHIV InfectionsCOINFECTION
Anna Cruceta 108
Testing effectiveness (Phase 2)Study completedNCT01016912
What this trial is testing

Safety and Efficacy of Daclatasvir (BMS-790052) Plus Standard of Care (Pegylated-interferon Alpha-2b and Ribavirin) in Japanese Patients

Who this might be right for
Hepatitis C Infection
Bristol-Myers Squibb 51
Large-scale testing (Phase 3)Study completedNCT02487030
What this trial is testing

Safety and Efficacy of Ledipasvir/Sofosbuvir Fixed Dose Combination, With or Without Ribavirin, in Egyptian Adults With Chronic Genotype 4 HCV Infection

Who this might be right for
Hepatitis C Virus Infection
Gilead Sciences 255
Not applicableEnrolling By InvitationNCT02699736
What this trial is testing

EuroSIDA - Clinical and Virological Outcome of European Patients Infected With HIV

Who this might be right for
HIVHepatitis BHepatitis C+10 more
Rigshospitalet, Denmark 23,000
Not applicableUnknownNCT03772002
What this trial is testing

Hepatitis C Surveillance With Linkage to Care of Patients From Non-ID Departments in Jiangsu

Who this might be right for
Hepatitis C, Chronic
The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School 600
Testing effectiveness (Phase 2)Study completedNCT00246363
What this trial is testing

A Clinical Research Study Designed To Determine If Treatment of Hepatitis C With Milk Thistle is More Effective Than No Treatment In Patients Infected With Both HIV And Hepatitis C

Who this might be right for
HIV InfectionsHepatitis C
Henry Sacks 40
Not applicableStudy completedNCT01772121
What this trial is testing

Observational Study on Prevalence of Host and Viral Genotypes in Chronic Hepatitis B and Hepatitis C Patients in India

Who this might be right for
Hepatitis BHepatitis C
Gilead Sciences 1,000
Post-approval studies (Phase 4)Study completedNCT00245414
What this trial is testing

Trial of Pegasys® in Patients With Chronic Hepatitis C

Who this might be right for
Chronic Hepatitis C
Chugai Pharmaceutical 108
Not applicableStudy completedNCT00441493
What this trial is testing

Fluvastatin Versus Hepatitis C Virus

Who this might be right for
Hepatitis C
Bader, Ted, M.D. 32
Testing effectiveness (Phase 2)Study completedNCT01435044
What this trial is testing

Safety Study of Regimens of Sofosbuvir, GS-0938, and Ribavirin in Patients With Chronic Hepatitis C Infection

Who this might be right for
Hepatitis C, Chronic
Gilead Sciences 239
Large-scale testing (Phase 3)Study completedNCT01358864
What this trial is testing

Efficacy and Safety of BI 201335 (Faldaprevir) in Combination With Pegylated Interferon-alpha and Ribavirin in Treatment-Experienced Genotype 1 Hepatitis C Infected Patients (STARTverso 3)

Who this might be right for
Hepatitis C, Chronic
Boehringer Ingelheim 678
Very early researchEnded earlyNCT00882193
What this trial is testing

Pilot Study of Betaine + Combination Antiviral Therapy for Chronic Hepatitis C Genotype 1 Non-responder/Relapsers

Who this might be right for
Chronic Hepatitis CGenotype 1Relapse
University of Nebraska 2
Testing effectiveness (Phase 2)Study completedNCT00656006
What this trial is testing

Albuferon With Ribavirin in Interferon Alfa Naive Subjects With Chronic Hepatitis C Genotype 2 or 3

Who this might be right for
Chronic Hepatitis C
Human Genome Sciences Inc. 43
Testing effectiveness (Phase 2)Study completedNCT01672983
What this trial is testing

Evaluate ABT-450 With Ritonavir (ABT-450/r) and ABT-267 in Japanese Adults With Chronic Hepatitis C Virus Infection

Who this might be right for
Chronic Hepatitis C Infection
AbbVie (prior sponsor, Abbott) 110
Next Page

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation